Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04649515
What this trial is testing

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 17
Not applicableUnknownNCT04852835
What this trial is testing

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Who this might be right for
COVID-19 Vaccines
University Hospital, Strasbourg, France 800
Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Not applicableActive Not RecruitingNCT04852289
What this trial is testing

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

Who this might be right for
COVID-19
National Institute on Aging (NIA) 78
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Testing effectiveness (Phase 2)UnknownNCT04396067
What this trial is testing

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Who this might be right for
COVID-19
Kafrelsheikh University 360
Not applicableStudy completedNCT04816084
What this trial is testing

SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes

Who this might be right for
Covid19
Université de Reims Champagne-Ardenne 389
Not applicableUnknownNCT04316728
What this trial is testing

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19

Who this might be right for
Coronavirus Infections
Centro Studi Internazionali, Italy 200
Early research (Phase 1)Study completedNCT04479644
What this trial is testing

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

Who this might be right for
COVID-19
Brii Biosciences Limited 17
Not applicableUnknownNCT04407429
What this trial is testing

Vienna Versus SARS-CoV-2 Virus Study

Who this might be right for
SARS-CoV-2COVID-19
Medical University of Vienna 12,000
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Not applicableStudy completedNCT05197673
What this trial is testing

Identifying Risks of COVID-19 Outbreaks in Work Settings and the Implications for Control Measures

Who this might be right for
Intention to Get SARS-CoV-2 VaccinationIntention to Get SARS-CoV-2 Antibody Test
Chinese University of Hong Kong 310
Early research (Phase 1)Study completedNCT04429529
What this trial is testing

Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 32
Not applicableUnknownNCT05561868
What this trial is testing

COVID-19 Antibody Responses in Cystic Fibrosis

Who this might be right for
Cystic FibrosisCOVID-19
Children's Health Ireland 70
Early research (Phase 1)Ended earlyNCT05135650
What this trial is testing

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Fred Hutchinson Cancer Center 20
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT05375760
What this trial is testing

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 251
Not applicableEnded earlyNCT04432779
What this trial is testing

Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children

Who this might be right for
PregnancyCovid-19
Centre Hospitalier Universitaire Saint Pierre 1,362
Not applicableStudy completedNCT04979871
What this trial is testing

SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19

Who this might be right for
Vaccine Reaction
University of Zurich 50
Not applicableStudy completedNCT04609085
What this trial is testing

SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

Who this might be right for
SARS-COV2 Virus
National Institute of Allergy and Infectious Diseases (NIAID) 730
Next Page